Brown, Landon C
1135  results:
Search for persons X
?
3

A phase 2 trial of avelumab in men with aggressive-variant ..:

Brown, Landon C. ; Halabi, Susan ; Somarelli, Jason A....
Prostate Cancer and Prostatic Diseases.  25 (2022)  4 - p. 762-769 , 2022
 
?
4

Evaluation of tumor microenvironment and biomarkers of immu..:

Brown, Landon C ; Zhu, Jason ; Desai, Kunal...
Journal for ImmunoTherapy of Cancer.  10 (2022)  10 - p. e005249 , 2022
 
?
6

LRP1Bmutations are associated with favorable outcomes to im..:

Brown, Landon C ; Tucker, Matthew D ; Sedhom, Ramy...
Journal for ImmunoTherapy of Cancer.  9 (2021)  3 - p. e001792 , 2021
 
?
7

Clinical outcomes in patients with metastatic renal cell ca..:

Brown, Landon C. ; Desai, Kunal ; Wei, Wei...
Journal for ImmunoTherapy of Cancer.  9 (2021)  9 - p. e003281 , 2021
 
?
9

Androgen receptor variant-driven prostate cancer II: advanc..:

Brown, Landon C. ; Lu, Changxue ; Antonarakis, Emmanuel S...
Prostate Cancer and Prostatic Diseases.  23 (2020)  3 - p. 367-380 , 2020
 
?
 
?
12

Androgen receptor variant-driven prostate cancer II: advanc..:

Lu, Changxue ; Brown, Landon C. ; Antonarakis, Emmanuel S...
Prostate Cancer and Prostatic Diseases.  23 (2020)  3 - p. 381-397 , 2020
 
?
13

Can RECIST response predict success in phase 3 trials in me..:

Brown, Landon C. ; Sonpavde, Guru ; Armstrong, Andrew J.
Prostate Cancer and Prostatic Diseases.  21 (2018)  3 - p. 419-430 , 2018
 
?
 
1-15